Institutional Biosafety Committee (IBC)

The IBC must review and approve all research and teaching projects involving hazardous biological materials, including:

• Recombinant DNA (as defined by the NIH Guidelines and including transgenic animals and plants)
• Select Agents (defined by 42 CFR Part 73, 9 CFR Part 121 and 7 CFR Part 331)
• All human pathogens, RG2 or greater
• Strict Animal and Plant Pathogens that are either reportable or non-indigenous to Georgia

It must also review and approve any diagnostic testing that involves the propagation of RG3 pathogens or Select Agents and Toxins.

This review ensures that work is conducted in a manner that does not pose significant risk to the health and safety of laboratory workers, the public, or the environment, and to ensure compliance with applicable external regulations and University of Georgia policies.

• IBC Protocol and Renewal Modification Submission Guide

IBC Meeting Calendar and Proposal Submission Deadline

IBC Meetings are held at noon to 2 p.m. on the fourth Thursday of every month in room 113, Riverbend South (Old CCRC) unless noted otherwise.

Protocols must be submitted for full IBC review no later than one month prior to the scheduled meeting date. Protocols received after that date will be put on the agenda for the following month's meeting.

IBC Membership

Silvia Moreno, Ph.D. – Chair